| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 12/27/2007 | 8:00AM | PR Newswire (US) | Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Periph | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/14/2007 | 4:05PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/11/2007 | 8:00AM | PR Newswire (US) | Allos Therapeutics to Present at the 2008 JPMorgan Healthcare Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/05/2007 | 8:00AM | PR Newswire (US) | Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/30/2007 | 5:37PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/29/2007 | 8:00AM | PR Newswire (US) | Allos Therapeutics to Present at the 2007 BMO Capital Markets Focus on Healthcare Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/20/2007 | 8:00AM | PR Newswire (US) | Allos Therapeutics to Present at the 2007 Lazard Capital Markets Healthcare Investor Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/12/2007 | 4:00PM | PR Newswire (US) | Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/07/2007 | 4:00PM | PR Newswire (US) | Allos Therapeutics to Present at the 2007 JMP Securities Healthcare Focus Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/05/2007 | 2:02PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/05/2007 | 8:03AM | Edgar (US Regulatory) | Allos Therapeutics Inc - Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/05/2007 | 7:30AM | PR Newswire (US) | Allos Therapeutics Reports Third Quarter 2007 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/31/2007 | 8:00AM | PR Newswire (US) | Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/25/2007 | 5:06PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/25/2007 | 4:01PM | PR Newswire (US) | Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/17/2007 | 4:58PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/16/2007 | 7:55AM | PR Newswire (US) | Allos Therapeutics to Report 2007 Third Quarter Financial Results on November 5, 2007 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/09/2007 | 4:51PM | Edgar (US Regulatory) | Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/26/2007 | 10:43AM | Edgar (US Regulatory) | Allos Therapeutics Inc (Other) (SC 13G) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/24/2007 | 3:35PM | Edgar (US Regulatory) | Allos Therapeutics Inc (Other) (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/24/2007 | 7:30AM | PR Newswire (US) | Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/13/2007 | 8:00AM | PR Newswire (US) | Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/04/2007 | 8:00AM | PR Newswire (US) | Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/15/2007 | 8:00AM | PR Newswire (US) | Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/07/2007 | 9:00AM | PR Newswire (US) | Allos Therapeutics Reports Second Quarter 2007 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/18/2007 | 8:00AM | PR Newswire (US) | Allos Therapeutics to Report 2007 Second Quarter Financial Results on August 7, 2007 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/25/2007 | 9:30AM | PR Newswire (US) | Allos Therapeutics Selected to Join Russel 3000 Index | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/19/2007 | 6:30AM | PR Newswire (US) | Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/31/2007 | 5:01PM | PR Newswire (US) | Allos Therapeutics Initiates Phase I/II Study of PDX and Gemcitabine in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Diseas | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |